Your browser doesn't support javascript.
loading
Outcomes of High-Dose Stereotactic Ablative Radiotherapy to All/Multiple Sites for Oligometastatic Renal Cell Cancer Patients.
Ma, Ming-Wei; Li, Hong-Zhen; Gao, Xian-Shu; Liu, Ming-Zhu; Yin, Huan; Yang, Kai-Wei; Chen, Jia-Yan; Ren, Xue-Ying; Wang, Dian.
Afiliação
  • Ma MW; Department of Radiation Oncology, Peking University First Hospital, Beijing 100034, China.
  • Li HZ; Department of Radiation Oncology, Peking University First Hospital, Beijing 100034, China.
  • Gao XS; Department of Radiation Oncology, Peking University First Hospital, Beijing 100034, China.
  • Liu MZ; Department of Radiation Oncology, Peking University First Hospital, Beijing 100034, China.
  • Yin H; Department of Health Science & Technology Strategy Information, Institute of Medical Information, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100006, China.
  • Yang KW; Department of Urology, Peking University First Hospital, Beijing 100034, China.
  • Chen JY; Department of Radiation Oncology, Peking University First Hospital, Beijing 100034, China.
  • Ren XY; Department of Radiation Oncology, Peking University First Hospital, Beijing 100034, China.
  • Wang D; Department of Radiation Oncology, Rush University Medical Center, Chicago, IL 60612, USA.
Curr Oncol ; 29(10): 7832-7841, 2022 10 17.
Article em En | MEDLINE | ID: mdl-36290896

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Radiocirurgia / Neoplasias Renais Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Radiocirurgia / Neoplasias Renais Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article